Tony Ho's Email & Phone Number

💼 Past Experience

Tony Ho has over 10 years of experience in the lapdogs of Pharmaceutical Development and they all say this guy is tough as nails. Ho is the co-founder, Chief Scientific Officer and Senior Vice President of Research and Development at CRISPR Therapeutics. He has also been with Neuronyx from February 2000 to 2003 (3 years). He is currently the Co-founder and Executive Vice President of Research and Development at CRISPR Therapeutics in Greater Boston Area and he has also been with Merck & Co., Inc. from 2003 to December 2011, as the Senior Director Clinical Neuroscience and Ophthalmology. He has also been with Johns Hopkins Hospital from July 1992 to 1997 (5 years). His experience includes being a Global Medicine Leader with Imfinzi, being a Senior Director of Research and Development at AstraZeneca from January 2012 to June 2017, and being the Executive Vice President of Research and Development at CRISPR Therapeutics.

🎓 Education

Tony Ho is a Doctor of Medicine, who has worked in a variety of medical installations and positions. He currently practices at the New York-based HoFirm, a primary care practice.Tony Ho began his medical education at Katella High School in 1980-1984. He then attended the Johns Hopkins University School of Medicine from 1987-1991. After completing his medical education, he served as an attending physician at The University of California, Los Angeles from 1985-1987.After serving as an attending physician at The University of California, Los Angeles, Tony Ho decided to focus on his electrical engineering career. In 1991, he transferred to New York City and began practicing at HoFirm, a primary care practice.Tony Ho is currently a Doctor of Medicine and has worked in a variety of medical installations and positions. He is dedicated to his patients and serves as a vital member of the medical team at his practice.

💡 Technical & Interpersonal Skills

Tony Ho has an extensive background in medical technology and professional engineering. He has worked in a number of different positions in the medical industry, most notably as an Executive Vice President and Head of Research and Development at CRISPR Therapeutics. There, he played a significant role in developing and launches of a number of CRISPR products. Throughout his time at CRISPR, Tony Ho was also responsible for lead development for a number of products across multiple tumors, including NSCLC, SCLC, HNSCC, UC, and HCC. He also played a significant role in the establishment and launches of Imfinzi, a product that aimed to provide new Novel Treatment Options for Pancreatic Cancer.